[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.157.225.99. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 27, 1971

Absorption and Metabolism of Levodopa

Author Affiliations

From the Department of Clinical Pharmacology, Hoffmann-La-Roche, Inc., Nutley, NJ. Dr. Abrams is now with Ayerst Laboratories, New York.

JAMA. 1971;218(13):1912-1914. doi:10.1001/jama.1971.03190260028007
Abstract

Although levodopa is a natural body substance, it is also a new drug, and as such, information is needed on the extent and rate of absorption, the distribution in the body, and the mechanisms and rate of elimination. Furthermore, the desired actions in the brain and the central and peripheral side effects appear to be due to one or more biotransformation products rather than to levodopa itself. The current hypothesis of the mechanism of action of levodopa holds that parkinsonism is due to a deficiency of the dopaminergic neurones in the substantia nigra which terminate in the corpus striatum.1 Dopamine itself cannot be used in treatment because of its inability to cross the blood-brain barrier. However, levodopa, an amino acid, enters the brain and is readily decarboxylated to dopamine. Thus, the metabolism of levodopa is of great clinical significance.

In our laboratories, absorption and metabolism studies have been conducted

×